Evidence map›Paper›PMID 38865197›Full record

ArticleACS infectious diseases2024

Investigating Penetration and Antimicrobial Activity of Vector-Bicycle Conjugates.

Andreas Hadjicharalambous, Hector Newman, Nick Lewis, Catherine Rowland, Nikolaos Bournakas, Steven J Stanway, Michael Dawson, Michael J Skynner, Paul Beswick

Abstract read
In one paragraph

Article in ACS infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Andreas HadjicharalambousDepartment of Biochemistry, University of Cambridge, Cambridge CB2 1QN, U.K.
Hector NewmanBicycleTx Limited, Portway Building, Granta Park, Cambridge CB21 6GS, U.K.ORCID 0000-0003-2429-996X
Nick LewisBicycleTx Limited, Portway Building, Granta Park, Cambridge CB21 6GS, U.K.
Catherine RowlandBicycleTx Limited, Portway Building, Granta Park, Cambridge CB21 6GS, U.K.
Nikolaos BournakasBicycleTx Limited, Portway Building, Granta Park, Cambridge CB21 6GS, U.K.
Steven J StanwayBicycleTx Limited, Portway Building, Granta Park, Cambridge CB21 6GS, U.K.
Michael DawsonBicycleTx Limited, Portway Building, Granta Park, Cambridge CB21 6GS, U.K.
Michael J SkynnerBicycleTx Limited, Portway Building, Granta Park, Cambridge CB21 6GS, U.K.
Paul BeswickBicycleTx Limited, Portway Building, Granta Park, Cambridge CB21 6GS, U.K.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Growing antibiotic resistance is rapidly threatening the efficacy of treatments for Gram-negative infections. Bicycle molecules, constrained bicyclic peptides from diverse libraries generated by bacteriophage display that bind with high affinity to a chosen target are a potential new class of antibiotics. The generally impermeable bacterial outer membrane currently limits the access of peptides to bacteria. The conjugation of membrane active peptides offers an avenue for outer membrane penetration. Here, we investigate which physicochemical properties of a specific membrane active peptide (MAP), derived from ixosin-B, could be tweaked to enhance the penetration of conjugates by generating multiple MAP-Bicycle conjugate variants. We demonstrate that charge and hydrophobicity are important factors, which enhance penetration and, therefore, antimicrobial potency. Interestingly, we show that induction of secondary structure, but not a change in amphipathicity, is vital for effective penetration of the Gram-negative outer membrane. These results offer insights into the ways vectors could be designed to deliver Bicycle molecules (and other cargos) through biological membranes.

Indexed as

Anti-Bacterial AgentsBacterial Outer MembraneGram-Negative BacteriaHydrophobic and Hydrophilic InteractionsMicrobial Sensitivity TestsPeptides, CyclicAnti-Bacterial AgentsPeptides, Cyclicantibioticsantimicrobial peptidesantimicrobial resistancebicyclemembrane active peptidesouter membrane

Identifiers

PMID38865197
PMCPMC11249977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.